Market Cap

Carna Biosciences, Inc. Market Capitalization:

¥4.36 Billion

JPY as of Jan. 1, 2026

US$27.8 Million

business Carna Biosciences, Inc. Company Profile

Carna Biosciences, Inc. Main Stock Listing

JPX: 4572

Market Capitalization History of Carna Biosciences, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Carna Biosciences, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2026 ¥4.36 B -26.67%
Jan. 1, 2025 ¥5.94 B -32.34%
Jan. 1, 2024 ¥8.78 B 37.28%
Jan. 1, 2023 ¥6.39 B -50.00%
Jan. 1, 2022 ¥12.79 B -28.93%
Jan. 1, 2021 ¥17.99 B -28.82%
Jan. 1, 2020 ¥25.28 B 84.78%
Jan. 1, 2019 ¥13.68 B -21.67%
Jan. 1, 2018 ¥17.47 B -41.54%
Jan. 1, 2017 ¥29.88 B 1.75%
Jan. 1, 2016 ¥29.36 B 209.40%
Jan. 1, 2015 ¥9.49 B -0.14%
Jan. 1, 2014 ¥9.50 B 74.23%
Jan. 1, 2013 ¥5.45 B 62.05%
Jan. 1, 2012 ¥3.37 B -36.15%
Jan. 1, 2011 ¥5.27 B -23.98%
Jan. 1, 2010 ¥6.94 B -40.76%
Jan. 1, 2009 ¥11.71 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Carna Biosciences, Inc. Categories

Japan languages Healthcare languages Biotechnology
Japan Healthcare Japan Biotechnology

Stocks & Indices

Carna Biosciences, Inc. has the following listings and related stock indices.


Stock: JPX: 4572

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.